Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.191
+0.021 (0.95%)
Aug 13, 2025, 4:00 PM - Market closed
Edesa Biotech Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2017 - 2019 |
| Cash & Equivalents | 12.36 | 1.04 | 5.36 | 7.09 | 7.84 | 7.21 | Upgrade
|
| Cash & Short-Term Investments | 12.36 | 1.04 | 5.36 | 7.09 | 7.84 | 7.21 | Upgrade
|
| Cash Growth | 505.70% | -80.65% | -24.39% | -9.55% | 8.67% | 43.40% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 0.09 | Upgrade
|
| Other Receivables | 0.29 | 0.27 | 0.63 | 1.26 | 3.3 | - | Upgrade
|
| Receivables | 0.29 | 0.27 | 0.63 | 1.26 | 3.3 | 0.09 | Upgrade
|
| Prepaid Expenses | 0.11 | 0.37 | 0.45 | 0.75 | 0.95 | 0.8 | Upgrade
|
| Total Current Assets | 12.76 | 1.68 | 6.44 | 9.09 | 12.09 | 8.1 | Upgrade
|
| Property, Plant & Equipment | - | 0.02 | 0.1 | 0.03 | 0.11 | 0.17 | Upgrade
|
| Other Intangible Assets | 2 | 2.08 | 2.18 | 2.28 | 2.38 | 2.48 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.17 | 0.17 | - | - | Upgrade
|
| Total Assets | 14.8 | 3.81 | 8.89 | 11.58 | 14.58 | 10.76 | Upgrade
|
| Accounts Payable | 0.67 | 1.81 | 1.75 | 2.12 | 1.38 | 1.46 | Upgrade
|
| Current Portion of Leases | - | 0.02 | 0.07 | 0.02 | 0.08 | 0.07 | Upgrade
|
| Total Current Liabilities | 0.67 | 1.83 | 1.82 | 2.14 | 1.46 | 1.53 | Upgrade
|
| Long-Term Leases | - | - | 0.02 | - | 0.02 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.04 | 0.05 | 0.03 | Upgrade
|
| Total Liabilities | 0.67 | 1.83 | 1.84 | 2.18 | 1.53 | 1.65 | Upgrade
|
| Common Stock | 54.27 | 47.24 | 46.64 | 42.47 | 34.89 | 18.5 | Upgrade
|
| Additional Paid-In Capital | 14.41 | 13.58 | 13.04 | 11.18 | 4.87 | 1.55 | Upgrade
|
| Retained Earnings | -63.65 | -58.59 | -52.42 | -44.04 | -26.5 | -13.13 | Upgrade
|
| Comprehensive Income & Other | -0.12 | -0.24 | -0.21 | -0.21 | -0.21 | -0.29 | Upgrade
|
| Total Common Equity | 4.91 | 1.98 | 7.05 | 9.39 | 13.06 | 6.63 | Upgrade
|
| Shareholders' Equity | 14.13 | 1.98 | 7.05 | 9.39 | 13.06 | 9.11 | Upgrade
|
| Total Liabilities & Equity | 14.8 | 3.81 | 8.89 | 11.58 | 14.58 | 10.76 | Upgrade
|
| Total Debt | - | 0.02 | 0.09 | 0.02 | 0.1 | 0.16 | Upgrade
|
| Net Cash (Debt) | 12.36 | 1.02 | 5.27 | 7.07 | 7.74 | 7.05 | Upgrade
|
| Net Cash Growth | 517.45% | -80.68% | -25.52% | -8.63% | 9.79% | 40.13% | Upgrade
|
| Net Cash Per Share | 2.62 | 0.32 | 1.84 | 3.37 | 4.49 | 5.73 | Upgrade
|
| Filing Date Shares Outstanding | 7.04 | 3.47 | 3.16 | 2.76 | 1.93 | 1.5 | Upgrade
|
| Total Common Shares Outstanding | 7.02 | 3.25 | 3.08 | 2.38 | 1.9 | 1.37 | Upgrade
|
| Working Capital | 12.09 | -0.16 | 4.61 | 6.95 | 10.63 | 6.57 | Upgrade
|
| Book Value Per Share | 0.70 | 0.61 | 2.29 | 3.95 | 6.88 | 4.83 | Upgrade
|
| Tangible Book Value | 2.91 | -0.1 | 4.87 | 7.11 | 10.68 | 4.15 | Upgrade
|
| Tangible Book Value Per Share | 0.41 | -0.03 | 1.58 | 2.99 | 5.62 | 3.02 | Upgrade
|
| Machinery | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | Upgrade
|
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.